Biodesix (BDSX) Depreciation and Depletion (2019 - 2026)

Biodesix (BDSX) has reported Depreciation and Depletion for 8 consecutive years, with $900000.0 the latest figure, recorded in Q1 2026.

• Depreciation and Depletion for Q1 2026 came in at $900000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.5 million (down 5.92% YoY), and the FY2025 annual result was $3.6 million, down 3.27% from the prior year.
• Depreciation and Depletion was $900000.0 for Q1 2026 at Biodesix, up from $842000.0 in the prior quarter.
• Over five years, Depreciation and Depletion peaked at $1.0 million in Q3 2024 and troughed at -$440000.0 in Q4 2023.
• Average Depreciation and Depletion over 5 years is $605235.3, with a median of $842000.0 recorded in 2025.
• Year-over-year, Depreciation and Depletion tumbled 204.27% in 2023 and soared 319.32% in 2024.
• Over 5 years, Depreciation and Depletion stood at $422000.0 in 2022, then sank by 204.27% to -$440000.0 in 2023, then jumped by 319.32% to $965000.0 in 2024, then retreated by 12.75% to $842000.0 in 2025, then grew by 6.89% to $900000.0 in 2026.
• Per Business Quant data, the three most recent Depreciation and Depletion figures were $900000.0 in Q1 2026, $842000.0 in Q4 2025, and $900000.0 in Q3 2025.